GLP-1 Receptor Agonist Market Report 2026 Global Outlook By Drug Class (Exenatide, Liraglutide, Dulaglutide, Lixisenatide, Other Drugs), By Route Of Administration (Parenteral, Oral), By End Users (Hospitals, Surgical Clinics, Other Users) Market Size, Trends, Strategies, and Forecast to 2035 GLP-1 Receptor Agonist Market Overview GLP-1 Receptor Agonist market size has reached to $14.09 billion in 2025 Expected to grow to $18.32 billion in 2030 at a compound annual growth rate (CAGR) of 5.4% Growth Driver: Surging Diabetes Cases Fuel Growth In Glp-1 Receptor Agonist Market Market Trend: Sustained-Release Glp-1 Receptor Agonists Are Gaining Popularity North America was the largest region in 2025 and Asia-Pacific is the fastest growing region
For instance, when comparing semaglutide with other GLP-1 receptor agonists (a class of drugs to which semaglutide belongs), the incidence of fever is consistently low across the board
Real-world health economic data shows that bariatric surgery leads to approximately 18% lower total medical costs over a two-year period compared to prescription drugs, while also achieving superior metabolic improvements
doi: 10.1080/07315724.2013.791194
CMD takes into consideration an individuals age, skin condition, aesthetic goals, previous cosmetic procedures, recovery needs, and lifestyle factors
doi: 10.1128/MCB.01300-08
